Concepedia

Anlin Hao

AH

6

Publications

228

Citations

6

H-Index

2019

Active since

Affiliations

Anyang Tumor Hospital(Current)

Fudan University

Fujian Medical University

First Affiliated Hospital of Henan University of Science and Technology

Chinese Academy of Medical Sciences & Peking Union Medical College

Anlin Hao is an author at Anyang Tumor Hospital specializing in medicine, cancer research, and cancer therapeutics.

Top concepts

MedicineHealthOncologyPathologyCancer TherapyCancer ResearchClinical TrialsSurgical OncologyRadiation OncologySurgery

Publications per year

2019–2024

6

Publications

6

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 144 citations · Full text

Surgical Oncology, Esophageal Cancer, Neoadjuvant Therapy +16

NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway

Yaowen Zhang, Anping Zheng, Ruiping Xu et al. · Biochemical and Biophysical Research Communications · 2019 · 34 citations

Cancer Research, Esophageal Cancer, Oncogenic Agent +8

Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial.

Yin Li, Jianjun Qin, Liyan Xue et al. · Journal of Clinical Oncology · 2024 · 15 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +16

Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy

Bo Yang, Anlin Hao, Lin Chen · Biomedicine & Pharmacotherapy · 2020 · 13 citations · Full text

Diagnosis of Esophageal Squamous Cell Carcinoma by High‐Performance Serum Metabolic Fingerprints: A Retrospective Study

Yida Huang, Haijun Yang, Junkuo Li et al. · Small Methods · 2023 · 12 citations · Full text

Rows per page

1–5 of 6